6BA Early efficacy signal demonstrated in advanced melanoma in a phase I trial of the oncogenic BRAF-selective inhibitor PLX4032
暂无分享,去创建一个
K. Flaherty | J. Sosman | A. Ribas | I. Puzanov | P. Chapman | Kevin B. Kim | G. McArthur | K. Nolop | Richard J Lee | J. Grippo